☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Eligible
Roche Reports Launch of First CDx VENTANA PD-L1 (SP142) Assay Identifying TNBC Patients Eligible for Treatment with Tecentriq (ate...
August 29, 2019
Samsung Bioepis Eticovo's (etanercept-ykro- biosmilar) Receives FDA's Approval for All Eligible Indication
April 29, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.
